Novo Nordisk wins big on strong US dollar
The sharply rising US dollar exchange rate compared to the Danish krone is very lucrative for Danish firms. Novo Nordisk is the clear winner, but many other healthcare companies also stand to benefit.
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
Danish business, with pharmaceutical flagship Novo Nordisk at the forefront, is winning big on a dramatic rise in the US dollar exchange rate.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Sonova loses Veterans Affairs market shares
For subscribers
